BioMedWire Stocks Archives - Page 2 of 82

ThursdayAug 06, 2026 10:00 am

Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients

While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients that initially respond well end up becoming unresponsive. Scientists have been working to develop tools that can help in predicting which patients are likely to benefit from immunotherapy, and a new liquid biopsy has provided a simpler way to do just that for patients with advanced lung cancer. According to a study that was published in the journal Clinical Cancer Research, a team at the Kimmel Cancer Research Center at Johns Hopkins together with their collaborators was able to develop a liquid biopsy that can accurately predict which patients will benefit from immunotherapy against…

FridayJul 31, 2026 10:00 am

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious diseases spread, and policymakers don’t seem to be taking this threat as seriously as they should. A sobering example is the 14 million cases of dengue fever that were recorded globally in 2024. This figure was double what had been documented in 2023, 7 million cases. A major contributor to this spike was the El Niño weather that occurred around that time. That spike in dengue cases was alarming, and it was also a warning sign that as the planet continued warming up, many more such massive outbreaks of infectious diseases…

ThursdayJul 30, 2026 10:00 am

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months from the time they are diagnosed with the malignancy. Existing treatments like surgery, chemotherapy and radiotherapy aren’t effective in halting the progression of this disease. Now, a new study shows that an experimental therapy containing vitamin B12 could halt GBM in its tracks. The study was conducted by a team at the Taussig Cancer Center of the Cleveland Clinic Foundation together with Nitric Oxide Services LLC. The researchers investigated a vitamin B12 compound called NO-Cbl (nitrosylcobalamin). This modified type of vitamin B12 releases nitric oxide. The purpose of the preclinical study was to look into whether this compound could…

TuesdayJul 28, 2026 10:00 am

Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response

For a long time, scientists have wondered why many individuals that have several risk factors linked to cancer development never develop the disease while some people without any of these risk factors go on to develop cancer. A team of researchers strongly thinks autoantibodies could provide major insights into why this happens, and they are planning to conduct studies aimed at understanding how autoantibodies influence the likelihood of cancer development, the progression of the disease, and how immune function is shaped in response to cancer development. The team, led by Doctor Laurent Casanova, has done extensive work on autoantibodies, immune proteins that bind to different molecules like the proteins found on viruses, bacteria and other pathogens. These…

FridayJul 24, 2026 10:00 am

Health Insurance Keeps 25% of US Employees Locked in Their Jobs

According to the findings of a recent poll conducted by Gallup and West Health, almost a quarter of employees within the U.S., or about 23 million individuals, remain doing jobs they would have otherwise left. They stay due to their desire to retain their health insurance. The data shows that “job lock” has been growing over the years and this latest survey indicates an increase of 8% from the number of people who reported being stuck in their jobs due to health insurance concerns in 2021. This comes as costs of healthcare are increasing to levels that are widely considered a crisis that needs to be fixed to tame rising medical…

ThursdayJul 23, 2026 10:00 am

Recent Communicable Disease Outbreaks Highlight Gaps in Public Health Systems

The U.S. has recently had outbreaks of a number of infectious diseases, such as measles, mpox and HIV. These outbreaks have exposed critical gaps that exist in public health systems, according to Doctor Monica Gandhi, a medicine professor at UCSF (University of California, San Francisco). She explains that these outbreaks have highlighted the various vulnerabilities that exist in an environment that is already plagued by worsening staff shortages and funding shortfalls. She points out that vaccine coverage is dropping rapidly, especially over recent years. Such a trend is creating room for vaccine-preventable infectious diseases like measles to re-emerge and affect a lot more people. The current policies of…

TuesdayJul 21, 2026 10:00 am

Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer

For a long time, many people have claimed that using a mobile phone can cause brain cancer. These fears were so widespread that the World Health Organization commissioned teams to conduct 13 reviews aimed at establishing whether electromagnetic waves, such as those that enable mobile phones to work, had any health effects. The reviews were commissioned back in 2019. The World Health Organization hasn’t released its own findings of those reviews. However, a study that was published last week provides an analysis of the WHO-funded reviews. The researchers show that the available data doesn’t provide any evidence to suggest that electromagnetic waves released by mobile phones cause brain cancer or cancer of the neck…

FridayJul 17, 2026 10:00 am

Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity

Scientists have been racing to establish why some patients respond to cancer immunotherapy while others do not. A recent study has linked metabolites produced by certain bacteria in the gut to improved responses to cancer immunotherapy in patients. The study, whose findings were published in the journal Cell Reports Medicine, was conducted by a large team led by researchers at the University of Nebraska and Cedars-Sinai, alongside collaborators based at other academic institutions. Ramer-Tait from the University of Nebraska led the research effort. Previous research has variously linked gut microbiota to improved responses to cancer immunotherapy. However, no study had pinpointed a specific microbe or microbial metabolite linked to immunotherapy response improvements…

ThursdayJul 16, 2026 10:00 am

Initiatives to Erase Medical Debt Gain Traction Across the US

According to KFF research conducted in 2022, about 100 million individuals in the U.S. are saddled with medical debt. This debt often makes it nearly impossible for them to afford other necessities of life, including additional medical care. As lawmakers on Capitol Hill drag their feet on enacting definitive remedies to the escalating healthcare costs, state governments and philanthropists are taking action to wipe medical debt away. Undue Medical Debt is a nonprofit organization that is focused on mobilizing donations and using the funds it gets to wipe away the crippling medical debt that low-income earners in the U.S. face. The nonprofit has come up with a model through which…

MondayJul 06, 2026 10:00 am

UCS Unveils Tool to Track Attacks Against Science in the US

The Union of Concerned Scientists (UCS) has unveiled an interactive tool geared toward documenting and highlighting the different ways through which science has come under attack from the time Trump took office for the second time. The tool also documents possible violations of draft legislation before Congress, called the Scientific Integrity Act. The tool, dubbed Attacks on Science Tracker, so far has a total of 576 attacks against science and 188 incidents that are categorized as possible violations of the Scientific Integrity Act. These cases span from January 2025 up to June 29, 2026. The developers of the tool aimed to bring to the public’s attention the different ways through which political and elected…